The Thoracic Oncology Group of Australasia (TOGA) will host its Small Cell Lung Cancer (SCLC) Masterclass on Friday, March 20, 2026, at the Novotel Melbourne on Collins.

This intensive, face-to-face workshop is designed for healthcare professionals to navigate a pivotal turning point in SCLC management, as novel therapies begin to challenge long-standing treatment paradigms. Chaired by A/Prof Surein Arulananda and Dr. Rebecca Tay, the program features international insights from Dr. Maurice Perol (France) on molecular subtypes and new directions, alongside Australian experts discussing limited-stage and extensive-stage standards of care. Through a combination of case studies and panel debates, participants will explore emerging data on checkpoint inhibitors, lurbinectedin, and tarlatamab, while addressing practical clinical challenges such as smoking cessation and the management of immune-related toxicities.

Register now.